Key Highlights

  • Rocket Lab (NASDAQ:RKLB) closed up 6.54% on November 10, 2026, reversing an early decline that followed its third quarter report.
  • Third quarter Revenue rose 73% to a record USD 267.8 million, above the company's USD 250 million to USD 265 million forecast.
  • Backlog jumped 52% in a quarter to a record USD 3.57 billion, helped by eight Neutron launch contracts worth more than USD 515 million.
  • The first Neutron flight has slipped to 2027, and the net loss widened to USD 79.7 million, including a USD 27.3 million Debt extinguishment charge.

Record Revenue and Backlog

Rocket Lab reported its results after the close on November 9, and the numbers were strong on growth. Revenue rose 73% to USD 267.8 million. Space Systems, which builds satellites, components and spacecraft, generated USD 214.8 million, up 88%, while Launch Services delivered USD 53.1 million, up 30%, from six Electron missions compared with four a year earlier. Adjusted gross Margin was 38.4%, above the 35% to 37% guidance range. The standout was backlog, which rose to USD 3.57 billion from USD 2.36 billion in June, with launch Backlog nearly doubling to USD 1.85 billion. During the quarter the company sold eight Neutron launches worth more than USD 515 million and raised the base price to USD 70 million from USD 55 million. Operating Cash Flow turned positive at USD 7.2 million, the first positive quarter in five, and cash and equivalents reached USD 4.45 billion.

Why the Stock Fell First, Then Rallied

The initial reaction was negative. Shares of Rocket Lab (NASDAQ:RKLB) fell about 6.7% after hours on November 9 as investors focused on the net loss of USD 79.7 million, or USD 0.12 per share, which was wider than expected and included a USD 27.3 million loss on extinguishment of debt. GAAP operating expenses of USD 169.3 million also exceeded guidance. Confirmation that the first Neutron flight has moved to 2027 weighed on sentiment, since the medium-lift rocket is central to the company's ambition to compete for larger constellation and national security payloads. By the regular session, buyers focused instead on the size and quality of the backlog and the fourth quarter outlook, and the stock closed 6.54% higher, an unusually large Reversal on a day when the Nasdaq fell 0.74% after hot Inflation data.

Guidance and the Neutron Question

Fourth quarter guidance supports the growth story. Management expects revenue of USD 270 million to USD 290 million, another record, with adjusted gross margin of 39% to 41% and an adjusted EBITDA loss of USD 14 million to USD 20 million. About 33% of the backlog is expected to convert within a year, down from 45% in June, which reflects the long-dated nature of new Neutron and constellation contracts. The main risk is execution. Neutron customers include ICEYE, Muon Space and the US Space Force, and further slippage could push revenue recognition later and raise development spending. Investors will watch for Neutron test milestones, the pace of Electron launches and margin progress in Space Systems, which now drives the bulk of revenue and profits. Progress toward sustained positive cash flow would also reduce reliance on the Capital Markets as development spending on Neutron continues.

Where Things Stand

Rocket Lab (NASDAQ:RKLB) rose 6.54% on November 10, 2026 as record revenue of USD 267.8 million and a USD 3.57 billion backlog outweighed a wider loss and a Neutron delay to 2027. Fourth quarter guidance of USD 270 million to USD 290 million points to continued growth. Neutron execution remains the critical variable for the stock over the next year.